GR
GRAIL Inc.
GRAL · NASDAQ
$126.89 +2.74% (+$3.39)
1M +59.87%
Market Cap $4.63B
P/E Ratio -
Div. Yield -
ROE 15.88%
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Moderate
4/9Valuation
46 /100
Fair P/B 1.82x
P/S 28.04x
P/FFO N/A
Growth
78 /100
Growing Book val. growth 17.83%
Rev. growth 38.37%
FCF growth N/A
Profitability
0 /100
Weak Op. margin 338.40%
Gross margin 10.83%
FCF margin 178.66%
Quality
1 /100
Poor ROA 13.77%
ROIC 14.93%
Asset turnover 0.06x
Debt
100 /100
Low Current ratio 10.95x
Debt/Equity 0.04x
Debt/Assets N/A
Stability
19 /100
Unstable EPS volatility 65.02%
Beta 3.25x
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about GRAL
Online
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Joshua J. Ofman
Employees
910
Headquarters
Menlo Park
Upcoming events
11 NOV
Earnings
Upcoming earnings report